Prasad ML, Patel SG, Huvos AG, Shah JP, Busam KJ
A dosage of Wegovy, a drug used for weight loss, on March 1, 2024, in Front Royal, Va
De hecho, algunos estudios reflejan una disminucin en el consumo de alcohol en pacientes tratados con semaglutida, pero esto est todava en evaluacin
[3] Researchers have questioned the relevance and validity of the rating scales and outcomes on which bremelanotide was assessed, as well as the drug's effect sizes for these, concluding that benefits may only be modest
KFF research found that 54% of adults who have taken GLP-1 drugs reported difficulty affording the therapy, with 22% stating it was very difficult. Geographic disparities: Patients in rural or underserved areas tend to face significant disparities in accessing GLP-1 therapies